Skip to main content
    N

    Natera Inc (NTRA)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $288.48
    -30.61 (-9.59%)

    Market Cap: $46.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Natera Inc (NTRA) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Natera (NTRA) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Natera reported EPS of -$0.39, below the -$0.17 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(21/40)
    Avg Surprise
    -0.35%

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.13
    Range-$0.39 - $0.05
    23 analysts
    Revenue Consensus
    $790.47M
    Range$723.14M - $837.90M
    23 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.23
    Range-$0.42 - -$0.07
    9 analysts
    EPS Revisions
    2
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.24+3.9%
    60d ago-$0.27+15.4%
    30d ago-$0.27+13.9%
    7d ago-$0.23+0.9%
    Current-$0.23
    Revenue Consensus
    $843.73M
    Range$774.80M - $883.80M
    14 analysts

    Next Report

    NTRA has an expected report date of Feb 24, 2027.

    NTRA Earnings Call

    The latest NTRA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, NTRA beat 21, missed 17 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $793.98M, up 34.1% from $592.18M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.39-$0.17-$0.61 - $0.13-129.41%MissN/A152 up, 4 downNov 5, 2026$793.98M
    Jun 30, 2026-$0.47-$0.47-$0.76 - -$0.300.00%In lineN/A132 up, 0 downAug 6, 2026$752.75M
    Mar 31, 2026-$0.60-$0.55-$0.68 - -$0.37-9.09%MissN/A131 up, 0 downMay 7, 2026$696.64M
    Dec 31, 2025$0.35-$0.46-$0.93 - -$0.20+176.09%BeatN/A143 up, 2 downFeb 26, 2026$665.50M
    Sep 30, 2025-$0.64-$0.35-$0.63 - -$0.17-82.86%MissN/A141 up, 0 downNov 6, 2025$592.18M
    Jun 30, 2025-$0.74-$0.60-$0.75 - -$0.40-23.33%MissN/A122 up, 1 downAug 7, 2025$546.60M
    Mar 31, 2025-$0.50-$0.66-$0.79 - -$0.47+24.24%BeatN/A132 up, 1 downMay 8, 2025$501.83M
    Dec 31, 2024-$0.41-$0.35-$0.62 - -$0.02-18.29%MissN/A133 up, 1 downFeb 27, 2025$476.06M
    Sep 30, 2024-$0.26-$0.59-$0.72 - -$0.48+55.93%BeatN/A180 up, 0 downNov 12, 2024$439.76M
    Jun 30, 2024-$0.30-$0.68-$0.79 - -$0.59+55.88%BeatN/A172 up, 0 downAug 8, 2024$413.35M
    Mar 31, 2024-$0.56-$0.71-$0.78 - -$0.65+21.13%BeatN/A152 up, 0 downMay 9, 2024$367.74M
    Dec 31, 2023-$0.64-$0.71-$0.87 - -$0.56+9.86%BeatN/A172 up, 0 downFeb 28, 2024$311.11M
    Sep 30, 2023-$0.95-$0.97-$1.09 - -$0.83+2.06%BeatN/A140 up, 1 downNov 8, 2023$268.31M
    Jun 30, 2023-$0.97-$1.10-$1.22 - -$0.98+11.82%BeatN/A151 up, 0 downAug 3, 2023$261.40M
    Mar 31, 2023-$1.23-$1.16-$1.28 - -$1.04-6.03%MissN/A151 up, 0 downMay 9, 2023$241.76M
    Dec 31, 2022-$1.37-$1.42-$1.58 - -$1.30+3.52%BeatN/A131 up, 0 downFeb 28, 2023$217.25M
    Sep 30, 2022-$1.25-$1.44-$1.52 - -$1.33+13.19%BeatN/A131 up, 0 downNov 8, 2022$210.64M
    Jun 30, 2022-$1.50-$1.50-$1.63 - -$1.370.00%In lineN/A120 up, 1 downAug 4, 2022$198.20M
    Mar 31, 2022-$1.45-$1.52-$1.74 - -$1.37+4.61%BeatN/A121 up, 0 downMay 5, 2022$194.13M
    Dec 31, 2021-$1.48-$1.31-$1.39 - -$1.12-12.98%MissN/A10N/AFeb 24, 2022$173.03M
    Sep 30, 2021-$1.63-$1.33-$1.36 - -$1.06-22.56%MissN/A10N/ANov 4, 2021$158.12M
    Jun 30, 2021-$1.32-$1.20-$1.40 - -$0.99-10.00%MissN/A11N/AAug 5, 2021$142.03M
    Mar 31, 2021-$0.74-$1.03-$1.13 - -$0.78+28.16%BeatN/A9N/AMay 6, 2021$152.32M
    Dec 31, 2020-$0.92-$0.62-$0.81 - -$0.48-48.39%MissN/A10N/AFeb 25, 2021$112.38M
    Sep 30, 2020-$0.72-$0.70-$0.77 - -$0.61-2.86%MissN/A9N/ANov 5, 2020$98.14M
    Jun 30, 2020-$0.68-$0.60-$0.73 - -$0.46-13.33%MissN/A6N/AAug 5, 2020$86.47M
    Mar 31, 2020-$0.45-$0.52-$0.68 - -$0.50+13.46%BeatN/A6N/AMay 6, 2020$94.01M
    Dec 31, 2019-$0.44-$0.55-$0.72 - -$0.38+20.00%BeatN/A6N/AFeb 26, 2020$83.24M
    Sep 30, 2019-$0.53-$0.55-$0.62 - -$0.47+3.64%BeatN/A6N/ANov 6, 2019$77.91M
    Jun 30, 2019-$0.48-$0.56-$0.62 - -$0.52+14.29%BeatN/A6N/AAug 7, 2019$74.36M
    Mar 31, 2019-$0.54-$0.60-$0.67 - -$0.52+10.00%BeatN/A6N/AMay 9, 2019$66.82M
    Dec 31, 2018-$0.51-$0.52-$0.58 - -$0.42+1.92%BeatN/A6N/AMar 12, 2019$66.97M
    Sep 30, 2018-$0.49-$0.48-$0.55 - -$0.38-2.08%MissN/A7N/ANov 8, 2018$65.28M
    Jun 30, 2018-$0.55-$0.57-$0.60 - -$0.41+3.51%BeatN/A8N/AAug 8, 2018$63.07M
    Mar 31, 2018-$0.61-$0.62-$0.84 - -$0.45+1.61%BeatN/A8N/AMay 8, 2018$62.34M
    Dec 31, 2017-$0.85-$0.47-$0.57 - -$0.37-80.85%MissN/A7N/AMar 13, 2018$52.05M
    Sep 30, 2017-$0.51-$0.48-$0.55 - -$0.42-6.25%MissN/A6N/ANov 8, 2017$55.91M
    Jun 30, 2017-$0.52-$0.54-$0.60 - -$0.46+3.70%BeatN/A6N/AAug 8, 2017$52.28M
    Mar 31, 2017-$0.70-$0.67N/A-4.48%MissN/AN/AN/AMay 9, 2017$49.38M
    Dec 31, 2016-$0.73-$0.61N/A-19.67%MissN/AN/AN/AMar 7, 2017$44.74M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.53, after -$1.53 the year before. It was -$1.86 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.53N/A
    Dec 31, 2024-$1.53N/A
    Dec 31, 2023-$3.79N/A
    Dec 31, 2022-$5.57N/A
    Dec 31, 2021-$5.17N/A
    Dec 31, 2020-$2.77N/A
    Dec 31, 2019-$1.99N/A
    Dec 31, 2018-$2.16N/A
    Dec 31, 2017-$2.58N/A
    Dec 31, 2016-$1.86N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,700 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,68811
    2026Q2Jun 30, 20268,86712
    2026Q1Mar 31, 20268,86115
    2025Q4Dec 31, 20257,36013
    2025Q3Sep 30, 20256,49213
    2025Q2Jun 30, 20258,65010
    2025Q1Mar 31, 20258,44411
    2024Q4Dec 31, 202411,15714

    2026Q3 Earnings Call

    Opening remarks

    Michael Brophy CFO Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our third quarter of 2026. On the line, I am joined by Steven Leonard Chapman, Solomon Moshkevich, and Alexey Aleshin. Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be posted to our investor relations website as soon as it is available. In the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook and projections, our assumptions for that outlook, market size, partnerships, clinical studies and expected results, opportunities and strategies, and expectations for various current and future products, including product capabilities, expected release dates, reimbursement coverage, and related effects on our financial and operating results. We caution you that such statements reflect our best judgment based on factors currently known to us and that actual events or results could differ materially. Please refer to the documents we file from time to time with the SEC, including our most recent Form 10-K or 10-Q and the Form 8-K filed today with today's press release. Those documents identify important risks and other factors that may cause our actual results to differ materially from those contained in or suggested by the forward-looking statements. Forward-looking statements made during the call are being made as of today, November 5, 2026. If this call is replayed or reviewed after today, the information presented during the call may not be current or accurate. Natera disclaims any obligation to update or revise any forward-looking statements. We will provide guidance on today's call, but we will not provide any further guidance or updates on our performance during the quarter unless we do so in a public forum. We will quote a number of numeric or growth changes as we discuss our financial performance. Unless otherwise noted, each such reference represents a year-over-year comparison. And now I would like to turn the call over to Steven. Steven?

    Steven Leonard Chapman CEO Hi, everyone, and thanks for joining us this afternoon. As you may have seen by now in the press release, I am stepping down from the CEO role, as now is an excellent time to transition to new leadership for Natera. We have had an incredible run during my time here since joining in 2010. My last almost eight years as CEO have been particularly meaningful to me, and I am extremely proud of all we have accomplished in that time.

    Frequently Asked Questions About NTRA

    When is Natera's next earnings date?

    Natera's next earnings report is expected for Feb 24, 2027.

    Did NTRA beat earnings estimates last quarter?

    No. Natera reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.17 estimate by 129.41%.

    What EPS do analysts expect from NTRA next quarter?

    The consensus EPS estimate for Natera for the quarter ending Dec 31, 2026 is -$0.13 from 23 analysts, with estimates from -$0.39 to $0.05.

    How often does NTRA beat earnings estimates?

    Natera beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -7.83%.